Repare Therapeutics Inc. Banner Image

Repare Therapeutics Inc.

  • Ticker RPTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Repare Therapeutics Inc. Logo Image
  • 51-200 Employees
  • Based in Montreal, Quebec
Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repairMore. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
5.0 / 5.0 (1)

Repare Therapeutics Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Repare Therapeutics Inc.

Most Recent Annual Report

Repare Therapeutics Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Repare Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!